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Abstract:  Detection  of  atherosclerotic  plaque  vulnerability  has  critical 
clinical implications for avoiding sudden death in patients with high risk of 
plaque  rupture.  We  report  on  multimodality  imaging  of  ex-vivo  human 
carotid plaque samples using a system that integrates fluorescence lifetime 
imaging  (FLIM),  ultrasonic  backscatter  microscopy  (UBM),  and 
photoacoustic  imaging  (PAI).  Biochemical  composition  is  differentiated 
with a high temporal resolution and sensitivity at the surface of the plaque 
by  the  FLIM  subsystem.  3D  microanatomy  of  the  whole  plaque  is 
reconstructed  by  the  UBM.  Functional  imaging  associated  with  optical 
absorption  contrast  is  evaluated  from  the  PAI  component.  Simultaneous 
recordings of the optical, ultrasonic, and photoacoustic data present a wealth 
of  complementary  information  concerning  the  plaque  composition, 
structure,  and  function  that  are  related  to  plaque  vulnerability.  This 
approach is expected to improve our ability to study atherosclerotic plaques. 
The  multimodal  system  presented  here  can  be  translated  into  a  catheter 
based intraluminal system for future clinical studies. 
©2011 Optical Society of America 
OCIS  codes:  (170.6510)  Spectroscopy,  tissue  diagnostics;  (300.6500)  Spectroscopy,  time-
resolved;  (110.7170)  Ultrasound;  (170.5120)  Photoacoustic  imaging;  (170.6935)  Tissue 
characterization. 
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Atherosclerotic cardiovascular disease (ACVD), a progressive disease of arteries, is one of the 
major causes of death worldwide [1]. Current techniques for investigation of atherosclerotic 
plaques  include  angiography,  intravascular  magnetic  resonance  imaging  (MRI),  optical 
coherence tomography (OCT) [2], intravascular ultrasound (IVUS) [3], optical spectroscopy 
(NIR, Raman, and fluorescence spectroscopy) [4,5], and photoacoustic imaging (PAI) [6]. 
However, a single imaging technique can only provide an incomplete characterization of the 
lesion.  More  complete  information  concerning  various  markers  involved  in  plaque 
vulnerability  and  rupture  is  needed  for  improving  plaque  evaluation  [7].  Typically  these 
markers encompass diverse features derived from plaque structure, composition, and function 
(e.g.  thinning  of  the  fibrous  cap,  large  lipid-rich  pool,  macrophage  presence  and  activity 
within fibrotic cap, and outward remodeling). 
This  pilot  study  investigates  whether  compositional,  structural,  and  functional 
characteristics of human atherosclerotic plaques can be evaluated concurrently via a flexible 
scanning  probe  composed  of  a  single  fiber-optic  and  a  single-element  high-frequency 
ultrasonic  transducer.  This  configuration  facilitates  integration  of  three  distinct  diagnostic 
modalities: fluorescence lifetime imaging (FLIM), ultrasonic backscatter microscopy (UBM), 
and  photoacoustic  imaging  (PAI),  and  acquisition  of  rigid-linked  co-registered  data  for 
characterization  of  human  atherosclerotic  plaque.  FLIM  has  demonstrated  potential  for 
characterization and mapping of the biochemical composition of the fibrotic cap within the 
superficial layer (~250 µm deep under UV excitation) and for distinguishing plaque features 
within  this  cap  that  have  been  related  to  plaque  vulnerability  [8,9].  UBM  employs  high-
frequency ultrasonic transducers (>40 MHz) that enable imaging of plaque microanatomy and 
morphology with high resolution (~50 µm) and penetration depth up to 4-5 mm [10]. UBM is 
applied  to  intravascular  setting  via  IVUS  rotational  catheter.  IVUS  systems  operating  at 
frequencies greater than 40 MHz have been used in patients for the analysis of arterial wall 
morphology [11]. PAI can map the differences in optical absorption of various molecular 
constituents of tissues. More recently, PAI has been suggested as a complementary technique 
to IVUS and investigated as a potential modality for detection of vulnerable plaques [12]. PAI 
showed potential to resolve the lipid-rich from collagen-rich regions based on the distinct 
optical absorption signature of these components. In this context, the technique reported here 
combining FLIM, UBM and PAI is expected to provide complementary information regarding 
features of atherosclerotic plaques, specifically those that are potential predictors of plaque 
rupture. 
While this study focuses on evaluating the ability of the hybrid (optical-ultrasonic) system 
to record via a compact probe multimodal data by linear-scanning, the approach reported here 
can  be  used  intravascularly  through  a  modified  IVUS  catheter  that  enables  rotational-
scanning.  Engineering  efforts  integrating  IVUS  and  fiberoptics  as  one  catheter  have  been 
previously reported [13,14]. 
2. Materials and Methods 
The multimodal imaging device included the following components: (1) a fast-speed time-
resolved  fluorescence  spectroscopy  (TRFS)  device  capable  of  simultaneously  recording 
fluorescence  decay  characteristics  in  multiple  spectral  bands  and  allowing  for 
dynamic/continuous recording of fluorescence signals that could be reconstructed into FLIM 
images  [15,16];  (2)  a  UBM  subsystem  designed  for  working  with  high-frequency  single-
element ultrasonic transducers; (3) a PAI subsystem sharing the electronics and the ultrasonic 
data  acquisition  pathway  with  the  UBM  subsystem  and  the  illumination  portion  with  the 
TRFS subsystem. Concurrent application of the three modalities was achieved using a hybrid 
imaging probe integrating coaxially a 600 µm silica optical fiber for fluorescence excitation-
collection and delivery of light for PAI and a press-focused ultrasonic transducer for UBM 
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stage (1 µm positioning accuracy) that permitted translation and positioning of the hybrid 
probe above the atherosclerotic plaque specimen. The setup allowed sequential acquisition of 
co-registered  FLIM-UBM-PAI  images.  A  detailed  description  and  a  complete 
characterization/validation  of  this  multimodal  imaging  system  will  be  reported  separately 
(manuscript  in  preparation).  Here,  we  limit  ourselves  to  briefly  describing  the  system 
specifications relevant to the current study of atherosclerotic plaques. 
2.1 FLIM Subsystem 
Fluorescence was induced by a pulsed nitrogen laser (337 nm, 0.7 ns) and detected via a gated 
MCP-PMT (180 ps rise time) and a fast digitizer (2.5 GHz bandwidth, 20 Gsamples/s). The 
rapid acquisition enabled 2D dynamic recording (scanning speed 0.2 mm/s) of time-resolved 
fluorescence from a tissue area of interest that in turn enabled the reconstruction of a set of 
fluorescence lifetime images in multiple spectral bands. The lifetime was defined as the 1/e 
decay  time  of  the  fluorescence  impulse  response  from  the  tissue  that  was  retrieved  via 
analytical models and Laguerre deconvolution algorithms [18]. For the current studies, the 
fluorescence emission was acquired and analyzed for three emission bands: 390 ± 20 nm; 450 
± 23 nm; and 540 ± 25 nm. These wavelength bands are sensitive to endogenous fluorophores 
within  the  vessel  walls  such  as  collagen,  elastin,  and  lipid  components.  Individual 
fluorescence  lifetime  values  for  each  scanning  line  were  analyzed  in  both  spectroscopic-
format (in order to determine the plaque composition at each location), and in image-format 
(to determine the plaque composition within a relatively larger area). In the FLIM image, the 
sample  area  for  data  acquisition  was  defined  by  the  fluorescence  excitation-collection 
geometry,  laser  repetition  rate  and  probe  scanning  speed.  Specifically,  in  the  current 
experiment, the pixel size of the image was 82 µm in the lateral scanning direction (x), and 
200 µm between frames (y). A 2D map of fluorescence lifetime of tissue was thus generated 
via  the  same  device  without  the  need  of  a  time-gated  imaging  camera  typically  used  in 
conventional  fluorescence  lifetime  imaging  microscopy  systems  [19].  The  prospect  of 
analyzing plaque composition for large areas via FLIM and determination of the extent of 
lipid-rich areas is important in diagnosing plaque at high-risk of rupture. 
2.2 UBM Subsystem 
The UBM component used a 41 MHz transducer (6 mm focal depth, 70% bandwidth, 3.75 
mm aperture size) and provided ultrasound images with an axial resolution of 37 µm and 
lateral  resolution  of  65  µm  [20].  Ultrasonic  backscatter  signals  were  detected  by  the 
transducer, amplified with a low noise amplifier by 35 dB, and recorded by a digitizer with a 
sampling rate of 400 M samples/s). Tomographic ultrasonic data were acquired by using the 
XYZ  positioning  stage  at  an  acquisition  speed  in  a  few  minutes.  The  dimension  of  the 
measurement cell was 0.02 (lateral, x) × 0.2 (between scanning frames, y) × 0.002 (in depth, 
z)  mm
3.  The  grey  scale  cross-sectional  UBM  images  with  structure  segmentation  were 
analyzed at every plane of interest and correlated with the spectroscopic signals or images. An 
intensity calibration curve as a function of depth was measured and used to compensate the 
intensity variations across the focal region of the ultrasound field. 
2.3 PAI Subsystem 
The PAI component was developed based on minimal modification of the configuration of the 
FLIM-UBM  system.  The  fiberoptic  probe  used  for  fluorescence  excitation/collection  was 
coupled to a frequency doubled pulsed Nd: YAG laser (532 nm, 10 ns, and average fluence of 
10 mJ/cm
2) to induce photoacoustic effect [6]. PAI data was acquired via the UBM transducer 
and  receiving  circuit  by  minor  modification  of  the  acquisition  software.  The  imaging 
resolution  of  the  PAI  subsystem  was  50  µm  and  70  µm  in  axial  and  lateral  direction, 
respectively. Although the PAI and UBM shared the same transducer for receiving the echoes, 
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resolution was determined not only by the transducer but also by the frequency characteristics 
of the photoacoustic response (affected by the absorber size and the laser pulse width [21]. 
The dimension of the PAI measurement cell was 0.02 (x) × 0.2 (y) × 0.004 (z) mm
3. The 
acquisition speed of the PAI data was 75 s/frame due to the low repetition rate (10 Hz) of the 
laser source. It was straightforward and feasible adding the PAI subsystem to the bimodal 
approach  (FLIM-UBM)  and  transforming  into  a  tri-modal  system  (FLIM-UBM-PAI)  for 
arterial plaque characterization/diagnosis. 
2.4 Tissue Samples and Histological Preparation and Analysis 
Multimodal imaging was conducted in human carotid atherosclerotic plaque samples within 
two  hours  of  endarterectomy.  Multimodal  measurements  from  two  human  carotid  plaque 
samples were acquired. After multimodal scanning, the orientation of the tissue specimen and 
location of the imaged region were marked with tissue ink and the sample was fixed in 10% 
formalin, embedded in paraffin, and processed routinely. Four micron tissue sections were 
stained with hematoxylin and eosin (H&E) and a combined trichrome/elastin method (mature 
collagen  stained  blue,  elastin  stained  black  and  smooth  muscle  cells  stained  red).  The 
histological results were used as a gold standard to correlate and validate the multimodal data. 
2.5 Image Processing and Co-Registration 
In the integrated probe, the UBM/FLIM portions are mechanically fixed with respect to the 
optical component. The transformation between the two images is therefore rigid. The offset 
of the optical fiber from the UBM transducer was directly measured and the corresponding X 
and Y translations (0.5 mm and 0.1 mm respectively) were applied to the images for overlay. 
No rotation of one system with respect to the other is possible in the setup. The UBM and the 
PAI  portions  are  also  mechanically  fixed  with  respect  to  each  other.  Therefore,  for  co-
registering  the  two  types  of  3D  data,  only  rigid  transformation  parameters  needed  to  be 
estimated.  We  fabricated  a  grid  phantom  from  carbon  fibers  (thickness:  ~20  μm)  for 
measuring  the  six  parameters  of  the  rigid  transformation.  The  thin  carbon  fibers  showed 
excellent  contrast  for  both  UBM  and  PAI  and  provided  means  for  determining  the 
transformation  at  close  to  the  spatial  resolution  of  both  systems.  The  phantom  was  first 
mechanically held horizontally in water along the focal plane of the system and underwent 3D 
scanning by UBM and PAI. 3D image matrices of reconstructed UBM and PAI were created 
with appropriate voxel dimensions. Mutual information-based rigid registration [22] was then 
carried out between the two imaging data sets and transformation parameters (translations: 
0.15, 0.9 and 0.5 mm in the X, Y and Z directions respectively, no rotational offsets) were 
recorded. The phantom was translated vertically for 2 mm on either side of the focal plane in 
steps of 250 μm and rescanned using both UBM and PAI. The task of rigid registration was 
repeated  at  each  position.  Only  negligible  differences  (<10  μm)  were  observed  in  the 
registration  parameters.  The  parameters  determined  through  this  process  were  used  to 
generate the results shown in this paper. 
3. Results 
3.1 Multimodal Measurements from Ex-Vivo Carotid Plaque 
A representative example was used to demonstrate the ability of the multimodal system to 
retrieve  complementary  characteristics  from  the  atherosclerotic  plaque  [Fig.  1].  The 
transducer-fiberoptic integrated probe used for the examination is shown in  Fig. 1(b). The 
fluorescence lifetime map acquired in three wavelength bands showed (1) the compositional 
changes at the lumen-surface of the plaque at specific wavelength bands, and (2) the changes 
of the trend of the lifetime along wavelengths for each type of composition [Fig. 1(c)–1(e)]. 
Both these variations were used to characterize plaque composition. For the 390 nm channel 
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against histopathological results that are independently from the multimodal measurement. 
The plaque type in the cyan circle area was determined to be collagen-rich fibrotic plaque 
from  histology.  From  FLIM,  a  longer  average  lifetime  of  3.12  ±  0.02  ns  was  observed, 
compared with the relatively normal area (magenta circle) that exhibited relatively shorter 
average lifetime of 2.0 ± 0.01 ns. The area shown by the black circle had mixed composition 
(collagen and lipids), as indicated by histology, and showed an average lifetime of 2.48 ± 0.01 
ns. The histograms of the lifetime values of the three locations are compared in Fig. 1(f). By 
observing  the  lifetime  over  the  three  wavelength  bands  [Fig.  1(c)–1(e)],  the  normal  area 
showed a slightly increased lifetime from 2.0 ns to 2.41 ns when the wavelength increased 
from 390 nm to 540 nm. In comparison, a different trend in the fibrous region (cyan circle) 
was  observed  where  the  lifetime  decreased  from  3.12  ns  to  2.55  ns  with  the  increasing 
wavelength.  UBM  images  for  each  transverse  plane  were  acquired  from  the  investigated 
region to form a fully 3D volumetric data set. Surface renderings of the UBM volume with 
representative orthogonal planes are shown in Fig. 1(g) and 1(h). The co-registered FLIM data 
was mapped on top of the UBM volume data showing the surface composition changes of the 
plaque [Fig. 1(i)]. In this manner, biochemical composition of the  plaque surface (i.e. the 
vessel lumen) was characterized by FLIM, and simultaneously anatomical information of the 
cross section at deeper locations was reconstructed from UBM. 
 
Fig. 1. Representative co-registered FLIM and UBM measurements of a human carotid plaque 
sample. (a) Photo of the carotid plaque sample with the imaging area outlined by the red 
dashed line (12.2 mm x 4 mm). (b) The combined probe integrating an ultrasonic transducer 
and an optical fiber. (c)-(e) FLIM images overlaid on top of the plaque photo at three different 
wavelengths, where the color represented average lifetime values from 0 ns to 4 ns for each 
pixel. Three regions were labeled in (c) and analyzed (f) Histogram of the average lifetime 
values at 390 nm from the three regions in (c) corresponding to three tissue types (IT: intimal 
thickening, FL: fibro-lipidic plaque, and FP: fibrotic plaque). (g)-(h) 3D UBM volume data 
from the investigated region (12.2 x 4 x 2 mm
3). Surface renderings of the UBM volume with 
orthogonal planes are shown with 45 dB displaying dynamics range and jet color map. (i) 
FLIM map at 390 nm coregistered with and overlaid onto a 3D UBM volume rendering. The 
minor differences in color scale between (c) and (i) are a by-product of 3D rendering. The PAI 
data can be displayed similarly but is not shown here to simplify the figure. 
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In order to demonstrate the advantages provided by each modality and to show how the three 
modalities complemented each other, detailed analysis of the multimodal data is summarized 
in Fig. 2. The regions spanned by four ROIs are shown in Fig. 2(a) and the mean lifetime 
value was averaged over the sampling number within each region. Histopathological analysis 
concluded that ROI-1 corresponded to intimal thickening, ROI-2 showed fibro-lipidic plaque 
with calcific deposits, ROI-3 showed intimal thickening, and ROI-4 indicated fibrotic plaque 
[arrows in Fig. 2(e)]. 
 
Fig. 2. Multimodal measurements and correlation analysis with histology from the scanning 
position indicated by the black dashed line in Fig. 1(c). (a) Plots of the average lifetime as a 
function of scanning position. Four ROIs were analyzed to show the changes in lumen-surface 
composition.  (b)  Transverse  UBM  images  from  the  same  position  as  (a)  showed  the 
reconstruction of the plaque structure, where an acoustic shadowing area indicated calcific 
deposits. (c) The PAI image provided optical absorption contrast and structural information. 
HS: hot spot. (d) Co-registered UBM and PAI images were fused as one combined image. (e) 
The corresponding trichrome stained tissue section. (f)-(k) Zoomed-in histological images of 
the regions labeled with HS1 to HS4 in (c): (f) HS1, trichrome staining showing fibro-lipidic 
plaque and calcification. Macrocalcification, and microcalcification deposits (tens of microns) 
were observed (dark blue circles), (g) HS1, H&E staining confirming the microcalcification, 
(h) HS2, trichrome staining demonstrating the fibrotic collagen-rich region (blue lines) and 
lipid-rich area underneath (white clefts), (i) HS2, H&E, (j) HS3, dense fibrotic knot and intimal 
thickening with elastin fibers (black lines) and smooth muscle cells (red), and (k) HS4, knot of 
collagen fibers. 
In Fig. 2(a), different tissue types showed distinct average lifetime values at each channel 
and trends that varied as a function of wavelength. At 390 nm, the average lifetimes of the 
ROIs were: 2.03 ± 0.02 ns, 2.48 ± 0.02 ns, 2.09 ± 0.02 ns, and 3.0 ± 0.05 ns, respectively. The 
four regions were also differentiable by the trends of the average lifetime over wavelength. 
For example, with increasing wavelength, the lifetime increased from 2.09 to 2.40 ns (15%) 
for the intimal thickening composition in ROI-3 (similar trend in ROI-1) and decreased from 
3.0 to 2.57 ns (17%) for the fibrotic plaque in ROI-4. 
Transverse UBM grey scale images, from the same location as where the fluorescence data 
was acquired, demonstrated anatomical structures based on acoustic contrast [Fig. 2(b)]. The 
UBM image reconstructed the structure of the cross section of the plaque and showed obvious 
delineation of the intimal and medial layers. Thickened intima at the top of the tissue cross-
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region  and  acoustic  shadowing  within  the  thick  fibrous  cap  in  ROI  2  indicated  calcific 
deposits. These features were also validated by histopathological analysis of the sample. 
Simultaneously acquired PAI maps provided optical absorption properties of the plaque 
sample  [Fig.  2(c)].  The  fused  UBM-PAI  image  in  Fig.  2(d)  allowed  the  analysis  of  the 
photoacoustic response from the carotid artery sample within the anatomical delineation of the 
plaque reconstructed by the UBM image. The UBM-PAI image shows ultrasound echo and 
photoacoustic  signal  correlation  in  the  fibrotic/calcific  regions  of  the  plaque.  The  low-
amplitude photoacoustic signal presented at the plaque-media boundary was also observed in 
the  UBM  images.  Within  this  specimen,  complex  compositions  were  observed  including 
collagen  fibers,  lipids,  calcification,  elastin  fibers,  and  microvessels  that  could  all  act  as 
optical absorbers [Fig. 2(e)]. Four regions  with relatively large photoacoustic signal (“hot 
spots” (HS1-HS4)) were delineated from Fig. 2(c) and compared against histology. Higher 
magnitude  of  photoacoustic  signals  appeared  to  come  from  fibrotic  regions  (majorly 
comprised of collagen fibers, HS2) or regions with calcification or microcalcification deposits 
(HS1) than areas with more lipids (circle area in HS2). A dense knot of collagen-rich tissue 
observed at HS3 and HS4 also led to an increase of overall photoacoustic response compared 
to the surrounding area [Fig. 2(j), 2(k)]. Correlated features retrieved from FLIM, UBM and 
PAI within four ROIs indicated in Fig. 3 were summarized in Table 1. The values are reported 
as mean ± standard error. 
Table 1. Quantification of the Multimodal (FLIM-UBM-PAI) Data for Plaque 
Characterization (4 Locations) 
Region scanning 
distance/ 
Modality 
ROI-1 
1.1 – 3.0 mm 
ROI-2 
3.0 – 8.1 mm 
ROI-3 
8.1 – 11.4 mm 
ROI-4 
11.4 – 11.8 mm 
FLIM (lifetime - ns) 
390 nm 
450 nm 
540 nm 
2.03 ± 0.02 
2.19 ± 0.01 
2.26 ± 0.04 
2.48 ± 0.02 
2.45 ± 0.02 
2.53 ± 0.03 
2.09 ± 0.02 
2.24 ± 0.01 
2.40 ± 0.01 
3.0 ± 0.05 
2.63 ± 0.05 
2.57 ± 0.01 
UBM: 
Image evaluation 
Main features 
Delineation 
of intima and 
media layers 
Hypoechoic & 
acoustic 
shadowing 
Delineation of 
intima and media 
layers 
Thickened 
fibrotic cap 
PAI: 
Feature evaluation 
Hot spot 
(artifact from 
sample 
holding pin) 
High PA 
intensity 
& hot spots 
Delineation of 
intima and media 
layers & hot 
spots 
Moderate PA 
intensity from 
fibrous cap 
Histology  Thin–intima 
elastin–rich 
media 
Heterogenous 
composition 
(collagen, lipids, 
calcification) and 
microstructure 
Thin–intima 
elastin–rich 
media 
Collagen-rich 
area 
Lifetime (ns) 
features in 
literature* [23] 
Intima 
thickening 
1.9-2.0 
Fibro–lipidic 
plaque 
2.4-2.5 
Intima thickening 
1.9-2.0 
Fibrotic plaque 
2.6-3.0 
*Average fluorescence lifetime values at 390 nm. 
A second scanning multimodal measurement from a different region as in Fig. 1 but from the 
same human carotid plaque was summarized in Fig. 3. This sample included three regions, 
histologically characterized as (from left to right): inflammation with macrophages, fibrotic-
calcific, and fibrotic plaque [Fig. 3(d) arrows]. The average lifetimes in the 540 nm filter band 
were: 1.24 ± 0.03 ns, 1.35 ± 0.03 ns, and 1.86 ± 0.03 ns, respectively [Fig. 3(a)]. The lifetime 
decreased 50% for lipid-rich regions in ROI-1 compared with the fibrotic plaque in ROI-3 at 
this long wavelength. These results are in agreement with our earlier publication on the time-
resolved fluorescence characteristics of carotid plaques [23]. The UBM image showed an 
increased hyperechoic region for both the calcific necrotic core under the fibrotic plaque in 
ROI-2 and dense collagen fibrotic region in ROI-3 [Fig. 3(b)]. The region in ROI-1 exhibited 
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features were also validated by histopathological analysis of the sample. The PAI image from 
the same location showed increased photoacoustic regions in ROI-2 and ROI-3 corresponding 
to the calcific and fibrotic region due to high scattering, which was consistent with the results 
in Fig. 2 [Fig. 3(c)]. The fused UBM and PAI image was shown in Fig. 3(d). 
 
Fig. 3. Example of the multimodal measurements from a different scanning location of the 
carotid plaque sample and data correlation. (a) Plots of the average lifetime as a function of 
scanning position. Three ROIs were analyzed to show the changes in surface composition. (b) 
Transverse UBM images from the same position as (a) showed the reconstruction of the plaque 
structure, where an acoustic shadowing area indicated calcific deposits. (c) The PAI image 
provided optical absorption contrast. (d) Co-registered UBM and PAI images were fused as one 
combined image. (e) The corresponding trichrome stained tissue section. (f)-(k) Zoomed-in 
histological  images  of  the  regions  labeled  with  arrows  in  (e):  (f)  and  (i) 
inflammation\macrophages,  (g)  fibrotic-calcific  region  using  the  trichrome  stain,  (j)  H&E 
staining confirming the presence of calcification, (h) and (k) fibrotic plaque, respectively 
4. Discussion and Conclusions 
The multimodal system reported here showed the ability to provide a wealth of data that is 
complementary for the characterization of atherosclerotic plaque. Importantly, this data can be 
obtained through an integrated and compact scanning probe that allows for acquisition of co-
registered data from a plaque/tissue volume and display (1D, 2D, or 3D) of these data based 
on distinct diagnostic needs. For example (Fig. 1) 3D-UBM and PAI images acquired from a 
relatively large plaque volume can be co-registered with a 2D-FLIM map at the lumen-surface 
of this volume to provide a qualitative assessment of the distribution of distinct structural and 
compositional features of the plaque. In addition (Figs. 2 and 3) specific 1D (line-scanning) of 
fluorescence data and the corresponding 2D UBM and PAI transverse images can be also 
extracted  from  the  interrogated  volume.  Such  subset  of  data  enables  a  more  quantitative 
interpretation of fluorescence emission, correlation of tissue composition (lumen-side) with 
the underlying structure, and understanding the relationship between changes in fluorescent 
signal as a function of plaque intima thickness and/or its composition. Such analysis can be 
performed for every position or line of interest. 
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distinguished using lifetime values at critical emission wavelength bands. The spectroscopic 
parameters  were  sensitive  to  the  compositional  changes  in  ratio  of  plaque  fluorophores: 
elastin, collagen, and lipids as well as the progression of atherosclerosis. For example, in Fig. 
2, the lifetimes in ROI-1 and 3 were similar since the tissue type in these regions were both 
intimal thickening, where the fluorescence originated from the mixture of a small amount of 
collagen  in  the  thin  intimal  layer  and  elastin  in  the  medial  layer  as  confirmed  by 
histopathology.  The  lifetime  in  ROI-3  was  slightly  longer  than  ROI-1  due  to  the  greater 
amount of collagen in ROI-3. The average lifetime of the fibrotic plaque in ROI-4 was 48% 
longer than the intimal thickening composition from ROI-1 because the average lifetime in 
ROI 4 was dominated by collagen fluorescence (3.0-4.0 ns) that has longer average lifetime 
than elastin (2.0-2.5 ns) [24]. Multiple features were observed in ROI-2 (rich in collagen and 
lipids) and the shorter average fluorescence lifetime of ROI-2 relative to the fibrotic plaque in 
ROI-4 denoted the contribution of the short lifetime of lipid components (0.5-1 ns) to the 
overall fluorescence decay [24]. The fluorescence features identified here are in agreement 
with previously reported extensive TRFS studies of carotid plaques [23,25] and underscore 
the role of fluorescence lifetime measurements in the evaluation of biochemical features in 
plaque intima. 
UBM cannot only be used to complement the TRFS data at the surface of the plaque, but 
can  also  provide  structural  features  at  locations  beyond  the  UV  light  penetration  depth. 
Furthermore, calcification was non-fluorescent at the excitation wavelength of 337 nm and 
cannot be detected by TRFS only, while UBM was sensitive to calcification (e.g. Fig. 2 ROI-
2)  and  therefore  enable  detection  of  calcified  regions  within  plaques.  The  use  of  UBM 
provides a number of advantages that can be exploited in future catheter implementations. For 
example, the UBM image resolution can be improved by using higher frequency transducers 
(i.e. 60-70 MHz) with a spatial resolution of ~20 µm. At the same time, the penetration depth 
can still reach 3 to 4 mm as compared to the penetration depth of OCT which is usually less 
than  2  mm  [2].  Plaque  evaluation  and  feature  extraction  can  be  achieved  not  only  by 
analyzing directly the gray scale B-mode images, but also by accessing the radiofrequency 
(RF) ultrasonic data which allowed for tissue composition characterization [26]. 
For PAI modality, a careful analysis of histological areas corresponding to distinct levels 
of photoacoustic signal intensity showed that the signal originating from lipid/macrophage 
regions was lower when compared with that originating from dense-collagen fibrous. These 
results are consistent with previous reports, showing the potential of PAI to resolve volumes 
defined  by  lipids/macrophages  since  this  exhibits  low  optical  absorption  properties  when 
compared to collagen-rich areas at the wavelength of 532 nm [12,27]. We hypothesized that 
the fibrotic or calcific regions were highly scattering and can result in an increase of local 
fluence,  and  therefore  the  magnitude  of  photoacoustic  signals  [27].  These  results  were 
observed consistently in all specimens/cross-sections [i.e. “hot spot” areas in Fig. 2(c) and 
Fig. 3(c)]. While additional studies (such as spectroscopic PAI) are required to confirm the 
role of lipids, different types of collagens, and elastin in the photoacoustic signal, the mapping 
of optical absorption properties in the PAI images was indicative of the physiological and 
pathological conditions of the tissue. As a result, a comprehensive assessment of the plaque 
including  compositional,  anatomical,  and  functional  imaging  at  high  resolution  became 
possible through the combined TRFS/FLIM-UBM-PAI technique described here. 
While the multimodal probe (single-fiberoptic and single-ultrasonic transducer) used in 
current  study  is  not  feasible  for  intravascular  applications,  current  results  establish  the 
framework  for  future  intravascular  implementation.  The  arterial  wall  scanning  can  be 
achieved  using  a  combined  catheter  probe  through  a  radial  scanning  rather  than  a  linear 
scanning as depicted here. All the knowledge generated from the UBM and PAI subsystems 
including image processing, feature extraction, and coregistration with fluorescence data can 
be translated to IVUS and intravascular photoacoustic imaging (IVPA). Specifically, the value 
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recording during a catheter pull-back in the axial direction can be demonstrated based on the 
expertise acquired in this study [28]. 
In conclusion, current results successfully demonstrate our ability to acquire rigid-linked 
multimodal  data  (FLIM,  UBM,  and  PAI)  that  allows  for  direct  data  co-registration. 
Specifically,  fluorescence  lifetime  images  in  multiple  spectral  bands  mapped  the  areas 
occupied  by  varying  biochemical  compositions  (i.e.  fibrotic,  lipidic,  elastin-rich,  etc.)  and 
provided the opportunity for enhanced detection of critical arterial wall pathologies. Two high 
resolution imaging techniques (UBM and PAI) were able to provide specific anatomical and 
functional images of the plaques (cross-section) and overcome the limited penetration depth 
of the TRFS/FLIM approach. A range of signal and image processing tools were implemented 
and tested for the analysis of the multimodal data obtained from atherosclerotic plaques. 
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